Stock GNPX GENPREX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Genprex, Inc.

Equities

GNPX

US3724462037

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-31 EDT 		5-day change 1st Jan Change
3.11 USD +28.51% Intraday chart for Genprex, Inc. +41.36% -66.20%
05-15 Genprex, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-14 Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa Immunogene Therapy in Combination with Tecentriq to Treat Small Cell Lung Cancer CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
GENPREX, INC.
Bio Therapeutic Drugs
+28.51%+41.36%-66.20%-91.68%-95.20% 6.52M
Neutral
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. GNPX Stock
  4. Charts Genprex, Inc.
  5. Comparison Chart